BR0313224A - Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicos - Google Patents
Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicosInfo
- Publication number
- BR0313224A BR0313224A BR0313224-2A BR0313224A BR0313224A BR 0313224 A BR0313224 A BR 0313224A BR 0313224 A BR0313224 A BR 0313224A BR 0313224 A BR0313224 A BR 0313224A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- composition containing
- pharmacological effects
- sexual dysfunction
- orally administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Confectionery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0202365A SE0202365D0 (sv) | 2002-08-05 | 2002-08-05 | New formulation and use thereof |
PCT/SE2003/001022 WO2004012702A1 (en) | 2002-08-05 | 2003-06-18 | New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0313224A true BR0313224A (pt) | 2005-07-05 |
Family
ID=20288677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0313224-2A BR0313224A (pt) | 2002-08-05 | 2003-06-18 | Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicos |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1539096A1 (ja) |
JP (1) | JP2005539008A (ja) |
CN (1) | CN1674866B (ja) |
AR (1) | AR040797A1 (ja) |
AU (1) | AU2003239038B2 (ja) |
BR (1) | BR0313224A (ja) |
CA (1) | CA2495527C (ja) |
IL (1) | IL166031A0 (ja) |
MX (1) | MXPA05000978A (ja) |
NZ (1) | NZ537520A (ja) |
RU (1) | RU2312665C2 (ja) |
SE (1) | SE0202365D0 (ja) |
TW (1) | TW200418470A (ja) |
WO (1) | WO2004012702A1 (ja) |
ZA (1) | ZA200500051B (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
GB0509317D0 (en) * | 2005-05-06 | 2005-06-15 | Clarke Anthony | Pharmaceutical formulation of apomorphine |
DE102010024866A1 (de) * | 2010-06-24 | 2011-12-29 | Pharmatech Gmbh | Formulierung zur Geschmacksmaskierung |
EP3299010B1 (de) | 2016-09-21 | 2022-11-09 | LTS Lohmann Therapie-Systeme AG | Orale darreichungsform |
CA3092458C (en) | 2018-03-01 | 2024-01-30 | Lts Lohmann Therapie-Systeme Ag | Oral dosage form containing theobromine-free cocoa |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4755180A (en) * | 1986-06-16 | 1988-07-05 | Alza Corporation | Dosage form comprising solubility regulating member |
FR2717387B1 (fr) * | 1994-03-17 | 1996-10-18 | Hi Pharmtech | Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline. |
US6121276A (en) | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
ES2105970B1 (es) * | 1995-08-02 | 1998-07-01 | S A L V A T Lab Sa | Composicion farmaceutica oral de ciprofloxacino, no acuosa, estable y con caracteristicas organolepticas mejoradas. |
CA2178021C (en) * | 1996-04-19 | 1999-09-28 | Theodore H. Stanley | Tobacco substitute |
DE69721559T2 (de) * | 1997-01-06 | 2003-11-27 | Pfizer | Geschmacksmaskierte pharmazeutische dosisform mit schneller freisetzung |
GT199900061A (es) * | 1998-05-15 | 2000-10-14 | Pfizer | Formulaciones farmaceuticas. |
JP2000095710A (ja) * | 1998-09-21 | 2000-04-04 | Taisho Pharmaceut Co Ltd | カカオ末を配合した経口用固形製剤 |
JP2000119198A (ja) * | 1998-10-16 | 2000-04-25 | Eisai Co Ltd | 苦味等の隠蔽されたホスフォジエステラーゼ阻害剤含有経口製剤 |
US6060094A (en) * | 1998-10-30 | 2000-05-09 | Nestec S.A. | Method of reducing fat in fat-based coating for confectionery products |
SE9803986D0 (sv) * | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
SI20109A (sl) * | 1998-12-16 | 2000-06-30 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Stabilna farmacevtska formulacija |
US6291471B1 (en) | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
US6455564B1 (en) * | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
EP1246605A2 (en) | 1999-08-10 | 2002-10-09 | The Board Of Regents, The University Of Texas System | Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow |
JP2001114668A (ja) * | 1999-10-13 | 2001-04-24 | Meiji Seika Kaisha Ltd | チョコレート剤 |
EP1242088A1 (en) | 1999-12-30 | 2002-09-25 | Tap Holdings, Inc. | Oral mucosal dosage forms of apomorphine |
AU2001273545A1 (en) | 2000-07-19 | 2002-01-30 | Lavipharm Laboratories, Inc. | Sildenafil citrate solid dispersions having high water solubility |
JP2002193839A (ja) * | 2000-12-27 | 2002-07-10 | Meiji Seika Kaisha Ltd | ココア製剤 |
CA2435546A1 (en) * | 2001-02-08 | 2002-08-15 | Alice C. Martino | Rapid-onset medicament for the treatment of sexual dysfunction |
US20020172732A1 (en) * | 2001-03-21 | 2002-11-21 | Wies Ter Laak | Composition comprising cocoa |
-
2002
- 2002-08-05 SE SE0202365A patent/SE0202365D0/xx unknown
-
2003
- 2003-06-18 MX MXPA05000978A patent/MXPA05000978A/es active IP Right Grant
- 2003-06-18 CA CA002495527A patent/CA2495527C/en not_active Expired - Fee Related
- 2003-06-18 CN CN038188910A patent/CN1674866B/zh not_active Expired - Fee Related
- 2003-06-18 NZ NZ537520A patent/NZ537520A/en not_active IP Right Cessation
- 2003-06-18 EP EP03733755A patent/EP1539096A1/en not_active Ceased
- 2003-06-18 BR BR0313224-2A patent/BR0313224A/pt not_active Application Discontinuation
- 2003-06-18 AU AU2003239038A patent/AU2003239038B2/en not_active Ceased
- 2003-06-18 JP JP2004525901A patent/JP2005539008A/ja active Pending
- 2003-06-18 WO PCT/SE2003/001022 patent/WO2004012702A1/en active Application Filing
- 2003-06-18 RU RU2005102835/15A patent/RU2312665C2/ru not_active IP Right Cessation
- 2003-07-25 TW TW092120418A patent/TW200418470A/zh unknown
- 2003-08-05 AR AR20030102814A patent/AR040797A1/es not_active Application Discontinuation
-
2004
- 2004-12-28 IL IL16603104A patent/IL166031A0/xx unknown
-
2005
- 2005-01-04 ZA ZA2005/00051A patent/ZA200500051B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2495527C (en) | 2008-12-30 |
JP2005539008A (ja) | 2005-12-22 |
WO2004012702A1 (en) | 2004-02-12 |
SE0202365D0 (sv) | 2002-08-05 |
CA2495527A1 (en) | 2004-02-12 |
RU2312665C2 (ru) | 2007-12-20 |
MXPA05000978A (es) | 2005-12-12 |
AU2003239038B2 (en) | 2008-01-03 |
ZA200500051B (en) | 2006-12-27 |
TW200418470A (en) | 2004-10-01 |
CN1674866B (zh) | 2012-09-26 |
IL166031A0 (en) | 2006-01-15 |
AR040797A1 (es) | 2005-04-20 |
NZ537520A (en) | 2006-11-30 |
RU2005102835A (ru) | 2005-08-10 |
CN1674866A (zh) | 2005-09-28 |
EP1539096A1 (en) | 2005-06-15 |
AU2003239038A1 (en) | 2004-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
AU1434000A (en) | Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
MY120279A (en) | Use of a celecoxib composition for fast pain relief | |
PL401469A1 (pl) | Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja | |
GEP20063799B (en) | Tropane derivatives useful in therapy | |
AR015820A1 (es) | Particulas de budesonida, composicion farmaceutica, uso de dichas particulas para la fabricacion de medicamentos, metodo para el tratamiento de untrastorno respiratorio y proceso para la preparacion de las particulas | |
PE20001032A1 (es) | Composiciones y metodos para tratar enfermedades pulmonares | |
ES2157307T3 (es) | Composicion topica que contiene un antagonista de sustancia p. | |
AR033548A1 (es) | Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares | |
SG152257A1 (en) | Topical preparation containing ambroxol | |
AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
BR0214289A (pt) | Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento | |
IL204947A0 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them | |
BR0209845A (pt) | Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
GB0406384D0 (en) | Composition for reducing appetite in mammals comprising proxyanidin | |
AR012417A1 (es) | COMPOSICIoN FARMACÉUTICA DE ADMINISTRACIoN ORAL Y PROCEDIMIENTO PARA SU PRODUCCION. | |
TR199802769T2 (xx) | Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim. | |
ES2191987T3 (es) | Formas de dosificacion de ribavirina solidas, administrables oralmente, y procedimiento de fabricacion. | |
BR0313224A (pt) | Composição farmacêutica contendo composto para terapia da disfunção sexual para ser administrada de modo oral que proporciona rápido inìcio de seus efeitos farmacológicos | |
BR0107899A (pt) | Processo para produzir uma preparação de ingrediente ativo compreendendo ibuprofeno, preparação de ingrediente ativo, uso da mesma, preparação farmacêutica, uso da mesma, processo para produzir formas de dosagem sólidas, e, forma de dosagem sólida | |
HUP0000137A2 (hu) | Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11 E 13 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |